Abstract

BackgroundBariatric surgery is the most effective treatment for patients with obesity and type 2 diabetes (T2DM), inducing profound metabolic changes associated with improvements in glycaemic control. In spite of the recognition of the physiological changes associated with bariatric surgery, what remains underappreciated is the patient experience of surgery to treat T2DM.ObjectivesThis study explored the patient experience with regard to motivations, expectations and outcomes, including remission and relapse of diabetes.MethodsAn in-depth qualitative approach was adopted, encompassing semi-structured interviews with patients (n=17) living with obesity and T2DM both pre- and postsurgery. Interpretive thematic analysis identified emergent themes using a grounded approach.ResultsAnalysis revealed a number of themes throughout the interviews which included motivations and perceived benefits of surgery, obesity stigma and its impact on self-worth as well as perceptions of remission or relapse and the implications for sense of control.ConclusionsThe motivation for undergoing bariatric surgery was driven by health concerns, namely T2DM and the desire to reduce the risk of developing diabetes-related complications. Patients highlighted social and self-stigmatisation associated with obesity and T2DM, leading to feelings of shame and an inability to seek support from family or healthcare professionals. Stigmatisation created a sense of failure and feeling of guilt for having T2DM. As a result, patients felt responsible for maintaining disease remission postoperatively and regarded the need for medication as a sign of treatment failure.

Highlights

  • The treatment of type 2 diabetes (T2DM) remains one of the most common indications for bariatric surgery given the rapid normalisation of glucose homeostasis it induces [1, 2]

  • Our understanding of obesity and T2DM as chronic and progressive conditions suggests that the efficacy of treatment reduces over time and a proportion of patients may experience a relapse of diabetes

  • Looking at outcomes in bariatric surgery, the focus is on weight loss, BMI, duration of disease remission and improvements in cardiovascular risk factors

Read more

Summary

Introduction

The treatment of type 2 diabetes (T2DM) remains one of the most common indications for bariatric surgery given the rapid normalisation of glucose homeostasis it induces [1, 2]. Our understanding of obesity and T2DM as chronic and progressive conditions suggests that the efficacy of treatment reduces over time and a proportion of patients may experience a relapse of diabetes. Looking at outcomes in bariatric surgery, the focus is on weight loss, BMI, duration of disease remission and improvements in cardiovascular risk factors. While these are undoubtedly important metrics to consider, the experience of patients undergoing bariatric surgery to treat obesity and T2DM is often overlooked. Bariatric surgery is the most effective treatment for patients with obesity and type 2 diabetes (T2DM), inducing profound metabolic changes associated with improvements in glycaemic control. Interpretive thematic analysis identified emergent themes using a grounded approach

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call